BBWI director buys 3,469.552 shares of stock at $14.4

Bath & Body Works, Inc. (BBWI) director reported an open-market purchase of common stock.

Rhea-AI Filing Summary

Bath & Body Works, Inc. (BBWI) director reported an open-market purchase of common stock. On 11/21/2025, the reporting person bought 3,469.552 shares of Bath & Body Works common stock at a weighted average price of $14.4 per share, coded as a purchase ("P").

After this transaction, the director beneficially owns 17,481.552 shares held directly. The price represents a weighted average, with individual purchase prices ranging from $14.40 to $14.425, and detailed breakdowns are available upon request to the company, the SEC staff, or a security holder.

Insider Trade Summary

Net Buyer: 3,469.552 shares

Net Buy 1 txn

Insider Brady Lucy

Role Director

Bought 3,469.552 shs ($50K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, $0.50 par value	3,469.552	$14.40	$50K

Holdings After Transaction: Common Stock, $0.50 par value — 17,481.552 shares (Direct)

Footnotes (1)

1. F1. Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $14.40 to $14.425. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BBWI disclose in this Form 4?

The filing reports that a director of Bath & Body Works, Inc. purchased 3,469.552 shares of common stock in an open-market transaction on 11/21/2025.

At what price did the BBWI director buy the shares?

The shares were purchased at a weighted average price of $14.4 per share, with individual trades executed between $14.40 and $14.425.

How many BBWI shares does the director own after this transaction?

Following the reported purchase, the director beneficially owns 17,481.552 shares of Bath & Body Works common stock, held directly.

What was the transaction code used in this BBWI Form 4 filing?

The transaction is reported with code "P", which indicates an open-market or private purchase of Bath & Body Works common stock.

Does this BBWI Form 4 involve any derivative securities?

No derivative securities are reported. The table for derivative securities shows no entries, indicating only non-derivative common stock was involved.

Who signed the BBWI Form 4 on behalf of the reporting person?

The Form 4 was signed by Robert J. Tannous as Attorney-in-Fact for the reporting person on 11/24/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 05:09 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brady Lucy

(Last) (First) (Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS OH 43230

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.50 par value	11/21/2025		P		3,469.552	A	$14.4(1)	17,481.552	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $14.40 to $14.425. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.

	Robert J. Tannous, Attorney-in-Fact	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.